Rubric Capital Management LP
About Rubric Capital Management LP’s 13F portfolio
Rubric Capital Management LP is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Rubric Capital Management LP reported $10.9B across 87 US-listed positions (). Its largest position is TALEN ENERGY CORP (TLN) at 13% of the reported book, and its ten biggest holdings make up 46% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | OTC: TLN TALEN ENERGY CORP | $355.91 −1.19% | 13% | 3.6M | $1.4B |
| 2 | NASDAQ: FTAI FTAI AVIATION LTD | $168.18 −2.36% | 7.4% | 3.0M | $811.6M |
| 3 | NASDAQ: VTRS VIATRIS INC | $19.88 −1.97% | 5.0% | 34.2M | $542.6M |
| 4 | NYSE: TEVA TEVA PHARMACEUTICAL INDS LTD | $38.54 −8.74% | 4.8% | 15.6M | $527.7M |
| 5 | NASDAQ: GLNG GOLAR LNG LTD | $40.40 −0.25% | 4.2% | 9.2M | $457.5M |
| 6 | NYSE: VST VISTRA CORP | $124.15 −1.14% | 2.6% | 1.8M | $284.7M |
| 7 | NYSE: TAC TRANSALTA CORP | $12.90 +0.86% | 2.6% | 20.2M | $279.8M |
| 8 | NYSE: FLR FLUOR CORP | $45.73 −3.79% | 2.4% | 5.0M | $262.9M |
| 9 | NASDAQ: KNSA KINIKSA PHARMACEUTICALS INTL | $93.54 −1.59% | 2.3% | 4.0M | $255.8M |
| 10 | NASDAQ: BGC BGC GROUP INC | $11.14 −1.33% | 2.3% | 23.8M | $254.4M |
| 11 | NASDAQ: ZM ZOOM COMMUNICATIONS INC | $83.82 −9.56% | 2.2% | 2.8M | $238.7M |
| 12 | NYSE: GIL GILDAN ACTIVEWEAR INC | $33.95 +1.59% | 2.1% | 4.5M | $232.2M |
| 13 | NASDAQ: ARQT ARCUTIS BIOTHERAPEUTICS INC | $27.17 −1.59% | 2.0% | 8.3M | $216.9M |
| 14 | NASDAQ: AMZN AMAZON COM INC | $257.37 −3.87% | 2.0% | 900K | $214.5M |
| 15 | NASDAQ: ROIV ROIVANT SCIENCES LTD | $38.96 +0.59% | 1.9% | 6.0M | $212.3M |
| 16 | NASDAQ: ZYME ZYMEWORKS INC | $26.86 +3.15% | 1.7% | 7.0M | $183.0M |
| 17 | NYSE: AMCR AMCOR PLC | $42.46 −2.84% | 1.7% | 4.2M | $180.4M |
| 18 | NASDAQ: CMPR CIMPRESS PLC | $54.24 −2.62% | 1.6% | 1.8M | $178.0M |
| 19 | NASDAQ: AMRX AMNEAL PHARMACEUTICALS INC | $21.39 −2.24% | 1.6% | 10.2M | $176.0M |
| 20 | NASDAQ: NRIX NURIX THERAPEUTICS INC | $13.60 −3.55% | 1.6% | 7.2M | $175.3M |
| 21 | NYSE: MCY MERCURY GENL CORP NEW | $82.59 −1.39% | 1.5% | 1.5M | $164.3M |
| 22 | NYSE: PFSI PENNYMAC FINL SVCS INC NEW | $58.40 −2.59% | 1.4% | 1.7M | $148.1M |
| 23 | NASDAQ: IART INTEGRA LIFESCIENCES HLDGS C | $13.55 −2.24% | 1.3% | 7.8M | $139.3M |
| 24 | NYSE: DK DELEK US HLDGS INC NEW | $60.25 −0.12% | 1.3% | 2.7M | $136.5M |
| 25 | NASDAQ: LBTYA LIBERTY GLOBAL LTD | $10.13 −1.94% | 1.2% | 11.8M | $133.6M |
Showing 1–25 of 87 positions on this page reported in this 13F.
- Healthcare33%
- Industrials14%
- Consumer Cyclical7.4%
- Energy6.0%
- Utilities5.8%
- Financial Services5.8%
- Communication Services4.1%
- Technology3.9%
- Consumer Defensive3.6%
- Real Estate1.2%
- Basic Materials1.2%
- AddedFTAIFTAI AVIATION LTD+16.5%$811.6M
- AddedVTRSVIATRIS INC+2.0%$542.6M
- AddedTEVATEVA PHARMACEUTICAL INDS LTD+2.1%$527.7M
- AddedVSTVISTRA CORP+19.7%$284.7M
- AddedTACTRANSALTA CORP+13.8%$279.8M
- NewFLRFLUOR CORP—$262.9M
- AddedKNSAKINIKSA PHARMACEUTICALS INTL+6.7%$255.8M
- AddedBGCBGC GROUP INC+2.1%$254.4M
- AddedZMZOOM COMMUNICATIONS INC+176%$238.7M
- AddedGILGILDAN ACTIVEWEAR INC+222%$232.2M
- ReducedAMRXAMNEAL PHARMACEUTICALS INC−7.9%$176.0M
- ReducedMCYMERCURY GENL CORP NEW−28.5%$164.3M
- ReducedECVTECOVYST INC−10.1%$102.2M
- ReducedEPCEDGEWELL PERSONAL CARE CO−11.4%$95.2M
- ReducedADEAADEIA INC−50.4%$70.0M
- ReducedPRMBPRIMO BRANDS CORPORATION−4.0%$65.3M
- ReducedTRVITREVI THERAPEUTICS INC−32.5%$46.7M
- ReducedPRLBPROTO LABS INC−77.7%$8.9M
- ReducedEDSAEDESA BIOTECH INC−2.6%$5.4M
- ReducedCRICARTERS INC−91.5%$3.6M
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | HRTX HERON THERAPEUTICS, INC. /DE/ | 13D | 15.9% | 30.0M | Filed 17 OCT 2025 |
| 2 | LILA Liberty Latin America Ltd. | 13G | 9.8% | 3.8M | Filed 15 MAY 2026 |
| 3 | ZYME Zymeworks Inc. | 13G | 9.5% · 2 classes | 7.0M | Filed 15 MAY 2026 |
| 4 | IART Integra Lifesciences Holdings Corporation | 13G | 9.5% | 7.4M | Filed 09 JUL 2025 |
| 5 | ECVT Ecovyst Inc. | 13G | 9.1% | 10.4M | Filed 14 NOV 2025 |
| 6 | NFE New Fortress Energy Inc. | 13G | 8.9% | 24.3M | Filed 14 MAY 2025 |
| 7 | MGTX MeiraGTx Holdings plc | 13G | 8.8% · 2 classes | 8.4M | Filed 16 NOV 2026 |
| 8 | KNSA Kiniksa Pharmaceuticals International, plc | 13G | 7.4% · 2 classes | 3.3M | Filed 13 FEB 2026 |
| 9 | AVO Mission Produce, Inc. | 13G | 6.8% | 6.0M | Filed 14 AUG 2026 |
| 10 | ARQT Arcutis Biotherapeutics, Inc. | 13G | 6.8% | 8.3M | Filed 13 FEB 2026 |
| 11 | OPK OPKO Health, Inc. | 13G | 6.0% | 47.8M | Filed 09 JUL 2025 |
| 12 | ABEO Abeona Therapeutics Inc. | 13G | 5.8% | 3.3M | Filed 16 NOV 2026 |
| 13 | MNKD MannKind Corporation | 13G | 5.8% | 18.0M | Filed 14 AUG 2026 |
| 14 | FUN Six Flags Entertainment Corporation | 13G | 5.8% | 5.9M | Filed 16 NOV 2026 |
| 15 | QDEL QuidelOrtho Corporation | 13G | 5.6% | 3.8M | Filed 13 FEB 2026 |
| 16 | ALVO Alvotech | 13G | 5.5% | 19.8M | Filed 16 NOV 2026 |
Showing all 16 disclosed stakes. 3 last disclosed over a year ago (the holder may since have dropped below 5%).
Reading Rubric Capital Management LP’s 13F portfolio
Rubric Capital Management LP’s $10.9B 13F book is spread across 87 reported positions and is concentrated toward its biggest ideas, with the top ten holdings at 46%. The largest positions carry real weight, so how those names perform matters a lot to the overall book. Its five largest positions are TLN, FTAI, VTRS, TEVA and GLNG, led by TALEN ENERGY CORP (TLN) at 13% of the portfolio. The heaviest sector exposure is Healthcare (33%), then Industrials (14%).
What Rubric Capital Management LP changed last quarter
Between 2026-03-31 and Q2 2026, Rubric Capital Management LP was a net buyer: it opened 18 new positions and added to 35 more, while trimming 10 and closing 13 outright. Against a 87-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was FTAI AVIATION LTD (FTAI), and its biggest reduction was AMNEAL PHARMACEUTICALS INC (AMRX).
What a 13F does and doesn’t reveal
A 13F captures only Rubric Capital Management LP’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Rubric Capital Management LP is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Rubric Capital Management LP's profile on this page is built directly from those filings.
How current is the 13F data on Rubric Capital Management LP's page?
It reflects Rubric Capital Management LP's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Rubric Capital Management LP files its next quarterly report, this page refreshes automatically.
Can I see Rubric Capital Management LP's complete list of holdings?
This page highlights Rubric Capital Management LP's largest positions rather than all 87 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Rubric Capital Management LP's filings.
Does a 13F show everything Rubric Capital Management LP owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Rubric Capital Management LP's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Rubric Capital Management LP made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

